In case you missed it: August 23 to August 27

Article

It was a busy week for the Contemporary OB/GYN® team.

This week's top articles included:

FDA grants full approval to COVID vaccine

On Aug. 23, the U.S. Food and Drug Administration granted full approval to the Pfizer-BioNTech coronavirus vaccine, which is a significant milestone in the pandemic. It is the first licensing of a vaccine for the novel coronavirus.

Sexual and reproductive health services from community pharmacists

The role of the community pharmacist has greatly expanded beyond traditional product-focused services to encompass a number of sexual and reproductive health (SRH) services, according to a review in BMJ Open.

System approved for highly automated cervical cancer screening

A high-throughput molecular diagnostic system that is fully automated has won approval from the U.S. Food and Drug Administration and now is available in the U.S. market for cervical cancer screenings.

Alcohol and tobacco use during pregnancy linked to stillbirth

Alcohol and tobacco use throughout the first trimester of pregnancy was associated with nearly 3 times the risk of late stillbirth (at 28 or more weeks), compared to women who neither drank alcohol nor smoked during pregnancy or quit both before the end of the first trimester.

Related Videos
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
raanan meyer, md
Related Content
© 2024 MJH Life Sciences

All rights reserved.